SS
Sushilaben Shatishkumar Patel
About Sushilaben Shatishkumar Patel
Data last updated:
Sushilaben Shatishkumar Patel has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Swana Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Swana Pharmaceuticals Private Limited at ₹0.16 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Swana Pharmaceuticals Private Limited U24231GJ1996PTC030921 | Director | 06 May 2019 | 1996 | ₹0.16 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sushilaben Shatishkumar Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sushilaben Shatishkumar Patel
Sushilaben Shatishkumar Patel has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Swana Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Swana Pharmaceuticals Private Limited at ₹0.16 Cr (FY 2025).
Sushilaben Shatishkumar Patel is associated with 1 company as Director, including Swana Pharmaceuticals Private Limited (₹0.16 Cr).
Sushilaben Shatishkumar Patel has expertise in General Business.
Sushilaben Shatishkumar Patel has 7 years in corporate governance.
By reported revenue, the largest current company of Sushilaben Shatishkumar Patel is Swana Pharmaceuticals Private Limited, with revenue of ₹0.16 Cr (FY 2025).
Sushilaben Shatishkumar Patel currently holds positions at 1 company: Swana Pharmaceuticals Private Limited (₹0.16 Cr).